Responses
Immunotherapy biomarkers
Original research
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
